Karius Inc. secures $100 million in Series C Funding

Karius, Inc., a pioneering company in the field of infectious disease detection, has announced a substantial $100 million Series C funding round. The investment was co-led by Khosla Ventures, 5AM Ventures, and Gilde Healthcare, with participation from new investor Seventure Partners and existing backers including Softbank Vision Fund 2 and General Catalyst. This infusion of…

Obsidian Therapeutics secures $160.5 million in oversubscribed Series C Funding

CAMBRIDGE: Obsidian Therapeutics, Inc., a trailblazer in engineered cell and gene therapies, has successfully completed a $160.5 million Series C financing round. This round was notably oversubscribed and led by Wellington Management, a new investor in the company. The funding round saw participation from a host of new investors, including Foresite Capital, Janus Henderson Investors,…